Adjuvant and additive therapy for cancer of the pancreas;Adjuvante und additive Therapie beim Pankreaskarzinom

Chirurg

Volumn 74, Issue 3, 2003, Pages 191-201

  Neoptolemos, J P ^a   Raraty, M G T ^a   Ghaneh, P ^a   Hickey, H ^a   Stocken, D D ^b   Dunn, J A ^b   Friess, H ^c   Buchler, M W ^c   Schemmer, Peter ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Additive therapy; Adjuvant therapy; Pancreas cancer

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DIPYRIDAMOLE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; PACLITAXEL; STREPTOZOCIN; ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; FOLIC ACID; MITOXANTRONE;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; PANCREAS CANCER; REVIEW; SURGICAL MORTALITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TIME; TUMOR RECURRENCE;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; DEOXYCYTIDINE; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLIC ACID; HEMATINICS; HUMANS; LEUCOVORIN; MALE; MITOXANTRONE; MULTICENTER STUDIES; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0037606120     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-003-0614-x     Document Type: Review

References (78)

1. Abrams RA, Grochow LB, Chakravarthy A et al. (1999) Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Rad Oncol Biol Phys 44:1039-1046
2. Abrams RA, Lillemoe KD, Piantadosi S (2001) Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet 358:1565-1566
3. Alfieri S, Morganti AG, Di Giorgio A et al. (2001) Improved survival and local control after intraoperative radiation therapy and post-operative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer. Arch Surg 136:343-347
4. Allen AM, Zalupski MM, Eckhauser FE et al. (2002) A phase I trial of radiation (RT) dose escalation with concurrent full dose gemcitabine (GEM) following resection of pancreatic cancer. Proc ASCO Abs 549
5. Andre T, Balosso J, Louvet C et al. (2000) Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys 46:903-911
6. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicenter study. Eur J Cancer 5:698-703
7. Baumel H, Huguier M, Manderscheid JC et al. ( 1994) Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 81:102-107
8. Beger HG, Gansauge F, Buchler MW, Link KH (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 23:946-949
9. Birkmeyer JD, Siewers AE, Finlayson EV et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137
10. Bramhall S, Dunn J, Neoptolemos JP (1998) Epidemiology of pancreatic cancer. In: Beger HG, Warshaw A, Carr-Locke DL et al. (eds) The Pancreas. (Two volumes). Boston, Blackwell Scientific, pp 889-906
11. Breslin TM, Hess KR, Harbison DB et al. (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123-132
12. Burris HA, Moore MJ, Andersen J et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
13. Chakravarthy A, Abrams RA, Yeo CJ et al. (2000) Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 48:1089-1096
14. Coia L, Hoffman J, Scher R et al. (1994) Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 30:161-167
15. Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223:273-279
16. Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915-923
17. Cullinan S, Moertel CG, Wieand HS et al. (1990) A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 65:2207-2212
18. Di Carlo V, Zerbi A, Balzano G, Villa E (1997) Intraoperative and postoperative radiotherapy in pancreatic cancer. Int J Pancreatol. 21:53-58
19. Dobelbower RR, Merrick HW, Khuder S et al. (1997) Adjuvant radiation therapy for pancreatic cancer: a 15-year experience. Int J Radiat Oncol Biol Phys 39:31-37
20. Douglass HO (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010
21. Farrell TJ, Barbot DJ, Rosato FE (1997) Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann Surg 226:66-69
22. Frederick WAI, Wolf RA, Crane CH et al. (2001) Preoperative (neoadjuvant) therapy for resectable adenocarcinoma of the pancreas. In: Evans DB, Pisters PWT, Abbruzzese JL, Pollock RE (eds) M.D. Anderson Solid Tumor Oncology Series. Springer, Berlin Heidelberg New York Tokyo, pp 243-254
23. Gansauge F, Link KH, Rilinger N et al. (1996) Adjuvant regional chemotherapy in resected advanced pancreas carcinoma. Chirurg 67:362-365
24. Ghaneh P, Magee C, Neoptolemos JP (in press) Pancreatic cancer. In: Williams C (ed) BMJ Evidence based oncology. BMJ Books, London
25. Glimelius B, Hoffman K, Sjödén PO et al. (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593-600
26. Hahn SA, Greenhalf W, Ellis I et al. (in press) BRCA2 germ line mutations in familial pancreatic carcinoma. JNCI
27. Halloran CM, Ghaneh P, Bosonnet L et al. (2002 Complications of pancreatic cancer resection. Digestive Surg 19:138-146
28. Halloran CM, Ghaneh P, Neoptolemos JP, Costello E (2001) Gene therapy for pancreatic cancer-current and prospective strategies. Surg Oncol 9:181-191
29. Haycox A, Lombard M, Neoptolemos JP, Walley T (1998) Current practice and future perspectives in detection and diagnosis of pancreatic cancer. Alimentary Pharmacology Therapeutics 12:937-948
30. Haycox A, Lombard M, Neoptolemos JP, Walley T (1998) Current treatment and optimal patient management in pancreatic cancer. Alimentary Pharmacology Therapeutics 12:949-964
31. Hishinuma S, Ogata Y, Matsui J, Ozawa I (1998) Results of surgery and adjuvant radiotherapy for pancreatic cancer. JHepato Biliary Pancreatic Surg 5:143-150
32. Hoffman JP, Lipsitz S, Pisansky T et al. (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 16:317-323
33. Ishikawa O, Ohigashi H, Imaoka S et al. (1994) Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg 129:1075-1080
34. Ishikawa O, Ohigashi H, Imaoka S et al. (1997) Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepato Gastroenterol 44:1541-1546
35. Ishikawa O, Ohigashi H, Sasaki Y et al. (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surgy 168:361-364
36. Johnstone PA, Sindelar WF (1993) Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys 27:831-834
37. Kachnic LA, Shaw JE, Manning MA et al. (2001) Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas. Int J Cancer 96:132-139
38. Kalser MH, Ellenberg SS (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899-903
39. Klaassen DJ, MacIntyre JM, Catton GE et al. (1985) Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group study. J Clin Oncol 3:373-378
40. Klinkenbijl JH, Jeekel J, Sahmoud T et al. (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776-784
41. Kokubo M, Nishimura Y, Shibamoto Y et al. (2000) Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int J Radiat Oncol Biol Phys 48:1081-1087
42. Komaki R, Wadler S, Peters T et al. (1992) High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer 69:2807-2812
43. Lee JH, Whittington R, Williams NN et al. (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 47:945-953
44. Link KH, Formentini A, Gansauge F et al. (1997) Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection. Digestion 58:529-532
45. Lowenfels AB, Maisonneuve P, Cavallini G et al. (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328:1433-1437
46. Lowenfels AB, Maisonneuve P, DiMagno EP et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442-446
47. Magee CJ, Greenhalf W, Howes N et al. (2001) Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications. Surg Oncol 10:1-23
48. Mallinson CN, Rake MO, Cocking JB et al. (1980) Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial. Br Med J 281:1589-1591
49. Mehta VK, Fisher G, Ford JA et al. (2001) Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 5:27-35
50. Mehta VK, Fisher GA, Ford JM et al. (2000) Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 48:1483-1487
51. Moertel CG, Childs DS, Reitemeier RJ et al. (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865-867
52. Moertel CG, Frytak S, Hahn RG et al. (1981) Therapy of locally unresectable pancreatic carcinoma: a randomised comparison of high dose (6000 rads) radiation alone, moderate dose radiation (400 rads+5-Fluorouracil), and high dose radiation+5-Fluorouracil: Gastrointestinal Tumour Study Group. Cancer 48:1705-1710
53. Neoptolemos JP, Baker P, Johnson CD et al. (1998) Adjuvant radiotherapy and follow-on chemotherapy in patients with pancreatic cancer. Results of the UK Pancreatic Cancer Group study (UKPACA-1). GI Cancer 2:235-245
54. Neoptolemos JP, Dunn JA, Stocken DD et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576-1585
55. Neoptolemos JP, Russell RCG, Bramhall SR, Theis B (1997) Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units. Br J Surg 84:1370-1376
56. Neoptolemos JP, Stocken DD, Dunn JA et al. (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758-768
57. Neoptolemos JP, Stocken DD, Dunn JA et al. (2002) Influence of the type of surgery and surgical complications in the ESPAC-1 adjuvant trial. Br J Surg 89:35 (abstract)
58. Nukui Y, Picozzi VJ, Traverso LW (2000) Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179:367-371
59. Ozaki H, Kinoshita T, Kosuge T et al. (2000) Long-term survival after multimodality treatment for resectable pancreatic cancer. Int J Pancreatol 27:217-224
60. Palmer KR, Kerr M, Knowles G et al. (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81:882-885
61. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4-S66
62. Paulino AC (1999) Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Am J Clin Oncol 22:489-494
63. Pedrazzoli S, Di Carlo V, Dionigi R et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy. In the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy study group. Ann Surg 228:508-517
64. Raraty MGT, Magee CJ, Ghaneh P, Neoptolemos JP (in press) Adjuvant therapy in pancreatic cancer. Acta Oncologica
65. Regine WF (2001 Postoperative adjuvant therapy: past, present and future trial development. In: Evans DB, Pisters PWT, Abbruzzese JL, Pollock RE (eds) M.D. Anderson Solid Tumor Oncology Series. Springer, Berlin Heidelberg New York Tokyo, pp 235-242
66. Sindelar WF, Kinsella TJ (1986) Randomized trial of intraoperative radiotherapy in resected carcinoma of the pancreas. Int J Radiat Oncol Biol Phys 12 [Suppl 1]:148
67. Snady H, Bruckner H, Cooperman A et al. (2000) Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 89:314-327
68. Sohn TA, Lillemoe KD, Cameron JL et al. (1999) Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. Ann Surg 229:393-400
69. Sohn TA, Yeo CJ, Cameron JL et al. (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567-579
70. Spitz FR, Abbruzzese JL, Lee JE et al. (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928-937
71. Splinter TA, Obertop H, Kok TC, Jeekel J (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. J Cancer Res Clin Oncol 115:200-202
72. Staley CA, Lee JE, Cleary KR et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:118-124
73. Wanebo HJ, Glicksman AS, Vezeridis MP et al. (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 135:81-87, Discussion 88
74. White R, Lee C, Anscher M et al. (1999) Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6:38-45
75. Willett CG, Lewandrowski K, Warshaw AL et al. (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217:144-148
76. Wong T, Howes N, Threadgold J et al. (2001) Molecular diagnosis of early pancreatic ductal adenocarcinoma in high risk patients. Pancreatology 1:486-509
77. Yeo C, Abrams R, Grochow L et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single institution experience. Ann Surg 225:621-633
78. Zerbi A, Fossati V, Parolini D et al. (1994) Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 73:2930-2935